SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (186)11/15/1997 10:11:00 PM
From: John McCarthy  Read Replies (1) of 569
 
Competition

This is a brief blurb about the sales force that will compete
against the AHP sales force, if ANIK can get their version
of Synvisc (OrthoVisc) passed by the FDA this qtr.

ANIK just signed a $23.0 deal with BMY.

FYI
------------
With the largest dedicated sales force addressing orthopaedic surgeons and related
specialties, we believe Zimmer will provide powerful commercialization and distribution
efforts to make ORTHOVISC the valued therapeutic option and preferred brand in the
treatment of osteoarthritis, " said J. Melville Engle, president and chief executive officer
of Anika. "Zimmer is the established world leader in knee replacement products and has
a strong reputation with orthopaedic surgeons and musculoskeletal specialists around
the globe."

pnp1.individual.com

Let's go AHP!

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News